K
Kaushiki Mazumdar
Researcher at University of Maryland, Baltimore
Publications - 38
Citations - 1427
Kaushiki Mazumdar is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Minimum inhibitory concentration & Antibiotics. The author has an hindex of 22, co-authored 38 publications receiving 1215 citations. Previous affiliations of Kaushiki Mazumdar include Jadavpur University & Tulane University.
Papers
More filters
Journal ArticleDOI
The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development.
TL;DR: It is shown that the viral nucleocapsid protein of SARS–CoV-2 contributes to forming helical ribonucleoproteins during the packaging of the RNA genome, regulating viral RNA synthesis during replication and transcription and modulating metabolism in infected subjects.
Journal ArticleDOI
Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium
Noton K. Dutta,Subramanian Annadurai,Kaushiki Mazumdar,Sujata G. Dastidar,Jette E. Kristiansen,Joseph Molnár,Marta Martins,Leonard Amaral +7 more
TL;DR: The ability of Dc to protect mice from a virulent Salmonella infection was determined and the non-antibiotic drug Dc has potential for the management of problematic antibiotic-resistant bacterial infections.
Journal ArticleDOI
The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target.
TL;DR: Diclofenac sodium was found to possess antibacterial activity against both drug-sensitive and drug-resistant clinical isolates of Staphylococcus aureus, Listeria monocytogenes, Escherichia coli, and Mycobacterium spp.
Journal ArticleDOI
Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
TL;DR: In this paper, Diclofenac was used in combination with the first-line antitubercular antibiotic streptomycin (STM) to improve its efficacy in vitro as well as in a murine tuberculosis infection model.
Journal ArticleDOI
Studies on the antibacterial potentiality of isoflavones
Sujata G. Dastidar,A Manna,K. Asok Kumar,Kaushiki Mazumdar,Noton K. Dutta,A. N. Chakrabarty,Noboru Motohashi,Yoshiaki Shirataki +7 more
TL;DR: Compounds YS19 and YS21 showed pronounced antimicrobial property and offered significant protection to mice challenged with 50 median lethal dose (MLD) of a virulent strain of Salmonella Typhimurium.